Black v. Novartis Pharmaceuticals Corporation
| Emma Black |
| Novartis AG and Novartis Pharmaceuticals Corporation |
| 3:2023cv01398 |
| November 28, 2023 |
| U.S. District Court for the Middle District of Florida |
| Patricia D Barksdale |
| Harvey E Schlesinger |
| Personal Inj. Prod. Liability |
| 28 U.S.C. ยง 1332 Diversity-Product Liability |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 16, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 MOTION to Transfer to MDL by Emma Black. (Attachments: #1 Exhibit Transfer Order)(Elias, Richard) Modified text on 1/17/2024 (BD). |
| Filing 11 CORPORATE Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Pharmaceutical Corporation for Novartis Pharmaceuticals Corporation. (Thomas, Michael) Modified on 12/22/2023 to edit text (ELM). |
| Filing 10 ANSWER and affirmative defenses to #1 Complaint with Jury Demand by Novartis Pharmaceuticals Corporation.(Thomas, Michael) |
| Filing 9 RETURN of service executed on 12/08/2023 by Emma Black as to Novartis Pharmaceuticals Corporation. (Elias, Richard) |
| Filing 8 ***INCORRECT EVENT CODE; COUNSEL NOTIFIED TO REFILE.*** PROOF of service by Emma Black (Elias, Richard) Modified on 12/18/2023 (LD). |
| Filing 7 NOTICE of Local Rule 3.02(a)(2), which requires the parties in every civil proceeding, except those described in subsection (d), to file a case management report (CMR) using the uniform form at www.flmd.uscourts.gov. The CMR must be filed (1) within forty days after any defendant appears in an action originating in this court, (2) within forty days after the docketing of an action removed or transferred to this court, or (3) within seventy days after service on the United States attorney in an action against the United States, its agencies or employees. Judges may have a special CMR form for certain types of cases. These forms can be found at www.flmd.uscourts.gov under the Forms tab for each judge. (Signed by Deputy Clerk). (TPL) |
| Filing 6 AMENDED Civil Cover Sheet by Emma Black. (Elias, Richard) Modified text on 12/4/2023 (LSS). |
| Filing 5 SUMMONS issued as to Novartis Pharmaceuticals Corporation. (KME) |
Filing 4
ENDORSED ORDER directing counsel to review the Local Rules, including Local Rule 1.08, which requires certain typefaces and sizes to ensure readability and equal content within page limits. Signed by Magistrate Judge Patricia D. Barksdale on 11/30/2023. (DS)
|
| Filing 3 NEW CASE ASSIGNED to Senior Judge Harvey E. Schlesinger and Magistrate Judge Patricia D. Barksdale. New case number: 3:23-cv-01398-HES-PDB. (AM) |
| Filing 2 NOTICE TO COUNSEL James G. Onder, Lawana S. Wichmann Local Rule 2.01(c), Special Admission of Non-Resident Lawyer - File a Motion to Appear Pro Hac Vice. Co-counsel with filing rights may electronically file the motion on behalf of the non-resident lawyer or the motion may be filed on paper; Pay the Special Admission Fee. (Signed by Deputy Clerk). (AM) |
| Filing 1 COMPLAINT against Novartis Pharmaceuticals Corporation with Jury Demand (Filing fee $402 receipt number AFLMDC-21502430) filed by Emma Black. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons)(Elias, Richard) (Modified on 11/29/2023, to edit text) (BGR). Modified text on 11/30/2023 (KME). |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
